Moore Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-125,000
| Closed | -$1.26M | – | 609 |
|
|
2022
Q4 | $1.26M | Hold |
125,000
| – | – | 0.03% | 296 |
|
|
2022
Q3 | $1.24M | Hold |
125,000
| – | – | 0.03% | 381 |
|
|
2022
Q2 | $1.22M | Hold |
125,000
| – | – | 0.03% | 365 |
|
|
2022
Q1 | $1.22M | Hold |
125,000
| – | – | 0.03% | 397 |
|
|
2021
Q4 | $1.21M | Hold |
125,000
| – | – | 0.02% | 433 |
|
|
2021
Q3 | $1.21M | Hold |
125,000
| – | – | 0.02% | 473 |
|
|
2021
Q2 | $1.21M | Buy |
+125,000
| New | +$1.21M | 0.02% | 485 |
|